L&K Biomed Ltd. (KOSDAQ:156100)

Market Cap	143.35B
Revenue (ttm)	33.18B
Net Income (ttm)	-1.50B
Shares Out	19.94M
EPS (ttm)	-75.11
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	79,378
Average Volume	37,609
Open	7,510.00
Previous Close	7,190.00
Day's Range	7,150.00 - 7,670.00
52-Week Range	5,930.00 - 10,400.00
Beta	1.61
RSI	53.88
Earnings Date	Mar 14, 2025

About L&K Biomed

L&K Biomed Ltd., a medical company, manufactures and sells spinal implants worldwide. It offers anterior and expandable lateral lumber cage systems; cervical interbody fusion cage, anterior cervical plate system, posterior cervical fixation system; spinal fixation screw, lumber plate, and spinal fixation systems, as well as posterior lumber interbody cage. The company also provides lateral and anterior lumber interbody cage, and transforaminal lumber interbody cage; MIS spinal and spinal fixation systems; and SI joint fusion system. L&K Biomed ...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2008
• Employees: 60
• Stock Exchange: KOSDAQ
• Ticker Symbol: 156100

Financial Performance

In 2023, L&K Biomed's revenue was 29.90 billion, an increase of 51.28% compared to the previous year's 19.77 billion. Losses were -1.87 billion, -86.30% less than in 2022.